Papers

2

Total Citations

11

H-Index

2

About

Dr. Naotaka Nishiyama is a urological surgeon whose research focuses on optimizing surgical outcomes for prostate cancer, with a particular emphasis on comparing modern minimally invasive techniques. His most cited work, a 2022 study with 9 citations, provides a critical comparison of therapeutic features and oncologic outcomes in pN1 prostate cancer patients undergoing robot-assisted, laparoscopic, or open radical prostatectomy. This contribution helps clarify the relative benefits of robotic surgery in advanced disease contexts. Dr. Nishiyama also investigates rare but clinically significant infectious complications in urological wards, as demonstrated by his 2017 case series on *Helicobacter cinaedi* bacteremia outbreaks following robotic prostatectomy. This work highlights the importance of infection control in surgical settings. His research bridges the gap between surgical technique and patient safety, offering practical insights for urologists. While his citation counts reflect a focused, early-career impact, his dual attention to oncologic efficacy and postoperative complications marks him as a thoughtful contributor to evidence-based urological practice.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy
9 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: University of Toyama, Kyushu University, Sapporo Medical University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago